Apoptosis provoked by the oxidative stress inducer menadione (vitamin K3) is mediated by the Fas/Fas ligand system

Clinical Immunology

Volumn 93, Issue 1, 1999, Pages 65-74

  Caricchio, Roberto ^a   Kovalenko, Dmitri ^a   Kaufmann, William K ^a   Cohen, Philip L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Apoptosis; Fas; Lymphocytes; Menadione; Oxidative stress

Indexed keywords

ANTIOXIDANT; FAS ANTIGEN; FAS LIGAND; GLUTATHIONE; MENADIONE SODIUM BISULFITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0032841904     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4757     Document Type: Article

References (52)

1. Cohen J. J. Apoptosis and its regulation. Adv. Exp. Med. Biol. 406:1996;11-20.
2. Hetts S. W. To die or not to die: An overview of apoptosis and its role in disease. JAMA. 279:1998;300-307.
3. Rudin C. M., Thompson C. B. Apoptosis and disease: Regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48:1997;267-281.
4. Rowan S., Fisher D. E. Mechanisms of apoptotic cell death. Leukemia. 11:1997;457-465.
5. Muzio M., Chinnaiyan A. M., Kischkel F. C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J. D., Zhang M., Gentz R., Mann M., Krammer P. H., Peter M. E., Dixit V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827.
6. Salvesen G. S., Dixit V. M. Caspases: Intracellular signaling by proteolysis. Cell. 91:1997;443-446.
7. Chinnaiyan A. M., Dixit V. M. The cell-death machine. Curr. Biol. 6:1996;555-562.
8. Cohen P. L., Eisenberg R. A. Fas/APO-1:a cell surface receptor that signals apoptosis. Gregory C. Apoptosis and the Immune Response. 1995;169-186 Wiley-Liss, New York.
9. Lynch D. H. The role of FasL and TNF in the homeostatic regulation of immune responses. Adv. Exp. Med. Biol. 406:1996;135-138.
10. Peter M. E., Heufelder A. E., Hengartner M. O. Advances in apoptosis research. Proc. Natl. Acad. Sci. USA. 94:1997;12736-12737.
11. Griffith T. S., Brunner T., Fletcher S. M., Green D. R., Ferguson T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
12. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
13. Hahne M., Rimoldi D., Schroter M., Romero P., Schreier M., French L. E., Schneider P., Bornand T., Fontana A., Lienard D., Cerottini J., Tschopp J. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape. Science. 274:1996;1363-1366.
14. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M., Krammer P. H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
15. Via C. S., Nguyen P., Shustov A., Drappa J., Elkon K. B. A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 157:1996;5387-5393.
16. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
17. Reap E. A., Roof K., Maynor K., Borrero M., Booker J., Cohen P. L. Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc. Natl. Acad. Sci. USA. 94:1997;5750-5755.
18. Caricchio R., Reap E., Cohen P. Fas/Fas ligand interactions are involved in UV-B-induced human lymphocyte apoptosis. J. Immunol. 161:1998;241-251.
19. Friesen C., Herr I., Krammer P. H., Debatin K. M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2:1996;574-577.
20. Packham G., Ashmun R. A., Cleveland J. L. Cytokines suppress apoptosis independent of increases in reactive oxygen levels. J. Immunol. 156:1996;2792-2800.
21. Liston P., Roy N., Tamai K., Lefebvre C., Baird S., Cherton-Horvat G., Farahani R., McLean M., Ikeda J. E., MacKenzie A., Korneluk R. G. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature. 379:1996;349-353.
22. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
23. Nishikawa Y., Carr B. I., Wang M., Kar S., Finn F., Dowd P., Zheng Z. B., Kerns J., Naganathan S. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J. Biol. Chem. 270:1995;28304-28310.
24. Wu F. Y., Chang N. T., Chen W. J., Juan C. C. Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene. 8:1993;2237-2244.
25. Illera V. A., Perandones C. E., Stunz L. L., Mower D. A. Jr., Ashman R. F. Apoptosis in splenic B lymphocytes: Regulation by protein kinase C and IL-4. J. Immunol. 151:1993;2965-2973.
26. Reap E. A., Leslie D., Abrahams M., Eisenberg R. A., Cohen P. L. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol. 154:1995;936-943.
27. Ju S. T., Panka D. J., Cui H., Ettinger R., El-Khatib M., Sherr D. H., Stanger B. Z., Marshak-Rothstein A. M. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:1995;444-448.
28. Matzinger P. The JAM test: A simple assay for DNA fragmentation and cell death. J. Immunol. Methods. 145:1991;185-192.
29. Buitenhuis H. C., Soute B. A., Vermeer C. Comparison of the vitamins K1, K2 and K3 as cofactors for the hepatic vitamin K-dependent carboxylase. Biochim. Biophys. Acta. 1034:1990;170-175.
30. Yaguchi M., Miyazawa K., Katagiri T., Nishimaki J., Kizaki M., Tohyama K., Toyama K. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid. Leukemia. 11:1997;779-787.
31. Jamison M., Gilloteaux J., Venugopal M., J. Koch A., Sowick C., Shah R., Summers J. L. Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells. Tissue Cell. 28:1996;687-701.
32. Taper H. S., Keyeux A., Roberfroid M. Potentation of radiotherapy by nontoxic pretreatment with combined vitamins C and K3 in mice bearing solid transplantable tumor. Anticancer Res. 16:1996;499-503.
33. Sun J. S., Tsuang Y. H., Huang W. C., Chen L. T., Hang Y. S., Lu F. J. Menadione-induced cytotoxicity to rat osteoblasts. Cell Mol. Life Sci. 53:1997;967-976.
34. Sata N., Klonowski-Stumpe H., Han B., Haussinger D., Niederau C. Menadione induces both necrosis and apoptosis in rat pancreatic acinar AR4-2J cells. Free Rad. Biol. Med. 23:1997;844-850.
35. Gottlieb R. A., Nordberg J., Skowronski E., Babior B. M. Apoptosis induced in Jurkat cells by several agents is proceded by intracellular acidification. Proc. Natl. Acad. Sci. USA. 93:1996;654-658.
36. Latinis K. M., Norian L. A., Eliason S. L., Koretzky G. A. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:1997;31427-31434.
37. Kasibhatla S., Genestier L., Green D. R. Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kB. J. Biol. Chem. 274:1999;987-992.
38. Faris M., Latinis K. M., Kempiak S. J., Koretzky G. A., Nel A. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligation promoter. Mol. Cell. Biol. 18:1998;5414-5424.
39. Bissonnette R. P., McGahon A., Mahboubi A., Green D. R. Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J. Exp. Med. 180:1994;2413-2418.
40. Brunner T., Mogil R. J., LaFace D., Yoo N. J., Mahboubi A., Echeverri F., Martin S. J., Force W. R., Lynch D. H., Ware C. F. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:1995;441-444.
41. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128.
42. Hueber A. O., Zornig M., Lyon D., Suda T., Nagata S., Evan G. I. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science. 278:1997;1305-1309.
43. Kossenjans W., Rymaszewski Z., Barankiewicz J., Bobst A., Ashraf M. Menadione-induced oxidative stress in bovine heart microvascular endothelial cells. Microcirculation. 3:1996;39-47.
44. Shertzer H. G., Lastbom L., Sainsbury M., Moldeus P. Menadione-mediated membrane fluidity alterations and oxidative damage in rat hepatocytes. Biochem. Pharmacol. 43:1992;2135-2141.
45. Deas O., Dumont C., Mollereau B., Metivier D., Pasquier C., Bernard-Pomier G., Hirsch F., Charpentier B., Senik A. Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells. Int. Immunol. 9:1997;117-125.
46. Williams M. S., Henkart P. A. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol. 157:1996;2395-2402.
47. Hug H., Strand S., Grambihler A., Galle J., Hack V., Stremmel W., Krammer P. H., Galle P. R. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J. Biol. Chem. 272:1997;28191-28193.
48. van den Dobbelsteen D. J., Nobel C. S. I., Schlegel J., Cotgreave I. A., Orrenius S., Slater A. F. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J. Biol. Chem. 271:1996;15420-15427.
49. Yin Y., Terauchi Y., Solomon G. G., Aizawa S., Rangarajan P. N., Yazaki Y., Kadowaki T., Barrett J. C. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature. 391:1998;707-710.
50. Miyake H., Hara I., Gohji K., Arakawa S., Kamidono S. p53 modulation of Fas/Apo-1 mediated apoptosis in a human renal cell carcinoma cell line. Int. J. Oncol. 12:1998;469-473.
51. Sheard M. A., Vojtesek B., Janakova L., Kovarik J., Zaloudik J. Up-regulation of Fas (CD95) in human p53 wild-type cancer cells treated with ionizing radiation. Int. J. Cancer. 73:1997;757-762.
52. Yeargin J., Cheng J., Haas M. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia. Leukemia. 6:1992;85S.